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Introduction 
Cardiac surgery is a complex area for 
outcome prediction with a considerable 
risk of mortality and morbidity.1 Various 
risk stratification scores can be used to 
predict outcome after cardiac surgery. 
However, to use an outcome it should be 
well defined, easily measured and 
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Abstract 
Background: Mortality is the most commonly used outcome measure 
after cardiac surgery. Various risk scores were developed to predict 
mortality after cardiac surgery with wide variability in risk stratification. 
We evaluated the accuracy of Acute Physiology and Chronic Health 
Evaluation II (APACHE II) score, Sequential Organ Failure Assessment 
(SOFA) score and Cardiac Surgery Score (CASUS) in predicting mortality 
in our patients. 
Methods: Between October 2015 and December 2017, 103 adult 
patients who underwent open heart surgery were evaluated. The 
clinical characteristics, outcomes and risk scores data of the patients 
were collected. Accuracy of the scores was assessed using receiver 
operating curve (ROC) and the multivariate logistic regression analysis. 
Results: 103 patients were enrolled with mortality rate of 10.3%.  The 
non-survivors group showed statistically significant lower ejection 
fraction (EF), higher platelet count, higher bilirubin level and lower PO2 
level (P value: 0.015, 0.020, 0.038, 0.006 respectively). Both APACHE II 
and SOFA scores performed better than CASUS score in predicting 
mortality in this study. However, APACHE II score (Area Under Curve 
“AUC”: 0.878, sensitivity: 80%, specificity: 78.5%) and the preoperative 
platelet count independently predicted mortality after cardiac surgery. 
Conclusion: Both APACHE II and SOFA scores showed the ability to 
predict mortality after cardiac surgery but APACHE II score rises as the 
best tool for risk stratification in our patient population. 
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objective. Mortality is the most commonly 
used outcome because it is relatively easy 
to determine.2 
Mortality following cardiac surgery 
ranges from 2.94 to 32.5% depending on 
the different types of surgery and 
populations.3-5 Numerous risk scores were 
developed to predict mortality after 
cardiac surgery but still there is wide 
variability among these scores with regard 
to score design and the initial population 
on which the score was developed.6 
The focus of risk scores was on the 
preoperative risk models, but most of 
them did not consider the intraoperative 
circumstances and the adverse effects of 
the cardiopulmonary bypass. For this 
reason, postoperative risk scores such as 
APACHE II score, SOFA score and CASUS 
score could be considered better in 
predicting outcomes.7 
Postoperative scores are widely used 
in mortality prediction after cardiac 
surgery but their validity in our patient 
population has not been tested. So, it was 
our aim to compare the ability of different 
scores in predicting clinical outcome after 
open heart surgery in our center. 
Patients and Methods: 
We included 103 patients who underwent 
open heart surgery in the period between 
October 2015 and December 2017. We 
excluded patients less than 18 years old, 
patients readmitted to the intensive care 
unit (ICU), emergency operations and 
patients with incomplete data.  
All available data of the study 
population including preoperative (full 
history, clinical examination and 
laboratory investigations), intraoperative 
(total bypass time, ischemic time and type 
of surgery) and postoperative data that 
included all available ICU data and 
investigations were recorded. Scoring 
systems were calculated from this 
database. Preoperative European System 
for Cardiac Operative Risk Evaluation 
(EuroSCORE) (additive and Logistic) was 
calculated in the routine preoperative 
workup. Ejection fraction (EF) was 
measured by M-mode echocardiography 
while estimated systolic pulmonary artery 
pressure was assessed by continuous wave 
doppler of the tricuspid flow. Patients with 
elevated pulmonary artery pressure were 
treated using sildenafil preoperatively and 
milrinone intraoperatively. 
SOFA score was calculated daily for 
maximum of 4 days,8 CASUS score was 
calculated on the 2nd and 4th day of ICU 
admission9 and APACHE II score was 
calculated in the first 24 hours of ICU 
admission.10 The worst data was taken for 
each variable of the scores. 
The main outcome measure was 30-day 
mortality. Other measures of outcome 
were expressed as: duration of ventilation 
and length of stay in the cardiac surgery 
intensive care unit (CSICU) and in the ward. 
Statistical analysis: 
The collected data were organized, 
tabulated and statistically analyzed using 
SPSS version 19 (Statistical Package for 
Social Studies) created by IBM, Illinois, 
Chicago, USA. For numerical values the 
mean and standard deviations were 
calculated. The differences between two 
mean values were used using Mann-
Whitney test. Normality was tested by 
Shapiro-Wilk test and assessed by 
histogram. For categorical variable the 
number and percentage were calculated 
and differences between subcategories 
were tested by Monte Carlo exact test. The 
correlation between two variables was 
calculated using Pearson’s correlation 
coefficient for normally distributed 
variables and spearman correlation for not 
normally distributed variables. 
Multivariate logistic regression was used 
for multivariate analysis of numerical 
variables affecting survival and Hosmer 
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Lemeshow test was used to express fitness 
of the model. The ROC curve was used to 
test predictability of survival by SOFA, 
CACUS and APACHE II. The level of 
significant was adopted at p<0.05. 
Results: 
The 103 patients were adults with a mean 
age of 45.02+13.15 years and 54.36% were 
females. The overall 30-day mortality was 
10.3%. The most common surgical 
procedure was mitral valve replacement 
(39 patients) followed by combined 
surgeries (20 patients), CABG (16 patients), 
aortic valve replacement (13 patients), 
double valve replacement (4 patients), ASD 
closure (2 patients), VSD closure (2 
patients) and other surgeries (7 patients). 
The preoperative characteristics of 
our patients were listed in Table 1. 
Compared to the survival group, the 
mortality group showed lower ejection 
fraction (54.10+9.72 percent, P-value: 
0.015), higher platelet count 
(285.40+67.42 X 103/mm3, P value: 0.020), 
higher bilirubin level (0.91+0.10 mg/dL, P-
value: 0.038) and lower PO2 level (78.00
+8.39 mmHg, P-value: 0.006). Table 2 
shows a comparison between the survival 
and mortality groups regarding the 
intraoperative and postoperative data. The 
mortality group showed a marked increase 
in the postoperative hours of ventilation 
(78.44+122.22 hours, P-value: 0.025). 
The estimated mortality was 17.52%, 
16.06%, 16% and 3.55% according to SOFA, 
APACHE II, CASUS scores and EuroSCORE 
respectively. Both APACHE II and SOFA 
scores showed satisfactory significance 
between survivors and non-survivors as 
shown in Table 2. The AUC listed in Table 
3 showed that both APACHE II and SOFA 
scores had a satisfactory ability in 
predicting mortality after cardiac surgery 
(AUC: 0.878, P-value: 0.001) and that both 
APACHE II and SOFA scores are better than 
CASUS score (AUC: 0.673, P-value: 0.108) 
in predicting mortality (Figure 1). The 
preoperative scores (EuroSCORE additive 
and logistic) showed no significant 
difference between survivors and non-
survivors as shown in Table 1. 
Figure 1: ROC curve for the three scores. 
According to the multivariate logistic 
regression analysis only the APACHE II 
score and the preoperative platelet count 
were independent predictors of mortality 
after cardiac surgery (Table 4). 
Regarding other outcome measures, all 
scores showed a significant correlation 
with the length of ICU stay and 
postoperative hours of ventilation. On the 
contrary none of the scores showed 
correlation with the length of hospital 
stay as shown in Table 5. 
Discussion: 
Our study population included 103 
patients who had cardiac interventions 
and admitted to ICU after open heart 
surgery. The overall 30-day mortality was 
10.3% which is considered to be higher 
than the average mortality reported in 
previous studies 9.3%, 9.6% and 6%.11-13 
This may be due to the higher rate of 
postoperative cardiac and respiratory 
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Table 1: Preoperative characteristics. Categorical variables are presented as numbers and percentage 
(%). Continuous variables are presented as mean+ SD 
Variable Survivors Non-survivors P-value 
Age in years 44.51+13.22 49.90+12.11 0.235 
Sex (Female) 49 (87.5%) 7 (12.5%) 0.339 
Body surface area 1.81+0.20 1.80+0.12 0.747 
Atrial fibrillation 32 (34.4%) 3 (30%) 1.000 
Diabetes mellitus 11 (11.8%) 3 (30%) 0.135 
Hypertension 9 (9.67%) 0 (0.0%) 0.594 
Previous cardiac surgery 7 (7.52%) 0 (0.0%) 1.000 
Pulmonary hypertension 41 (44.08%) 5 (50%) 0.749 
Ejection fraction 61.66+8.04 54.10+9.72 0.015 
Hemoglobin 12.04+1.42 11.85+0.71 0.721 
Platelets count (X103) 232.32+64.41 285.40+67.42 0.020 
Total leucocyte count (X103) 7.09+2.31 7.29+1.81 0.533 
Albumin 3.83+0.31 3.68+0.40 0.229 
Bilirubin 0.83+0.30 0.91+0.10 0.038 
Blood urea 31.42+8.92 30.50+11.47 0.381 
Creatinine 0.91+0.21 0.89+0.19 0.765 
INR 1.10+0.09 1.10+0.09 0.345 
Prothrombin activity 87.99+8.74 88.10+13.75 0.384 
pH 7.47+0.07 7.44+0.03 0.100 
PCO2 34.40+4.30 35.73+7.02 0.203 
PO2 107.09+54.27 78.00+8.39 0.006 
HCO3 26.19+3.99 25.79+2.99 0.738 
Serum potassium 3.84+0.41 3.80+0.41 0.614 
EuroSCORE additive 3.82+1.82 4.10+2.23 0.759 
EuroSCORE logistic 3.42+2.30 3.77+2.50 0.880 
*INR: International normalized ratio
complications. Twenty-seven over 103 
patients (26.2%) had cardiac complications 
while 16/103 patients (15.5%) had 
respiratory complications. This explanation 
was consolidated by the results of the 
univariate analysis that identified 
preoperative EF and PO2 as predictors of 
postoperative mortality. Among the 
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 Table 2: Intraoperative and postoperative data 
Variable Survivors Non-survivors Z P 
APACHE II 10.85+3.99 10.10+5.30 3.936 0.001 
Maximum SOFA 5.91+2.54 10.44+3.05 3.754 0.001 
Maximum CASUS 6.13+2.00 9.38+4.34 1.608 0.108 
Ischemic time 89.02+38.82 107.25+36.30 1.394 0.163 
Total bypass time 124.98+46.69 158.13+49.67 1.769 0.077 
ICU stay in days 3.97+3.38 5.70+4.64 0.941 0.347 
Hours of ventilation 8.53+8.87 78.44+122.22 2.239 0.025 
preoperative data 34/103 patients (33%) 
had severe pulmonary hypertension which 
is considered a high surgical risk and 
associated with higher likelihood of 
cardiopulmonary complications.14 
Many studies have been conducted on 
risk models after cardiac surgery 
estimating mortality and morbidity, but to 
date, there is no consensus regarding the 
best scoring system after cardiac surgery.15 
Our results showed that the preoperative 
score (EuroSCORE) underestimated the 
mortality risk in our patient population. 
The poor performance of the preoperative 
score could be attributed to the fact that 
EuroSCORE is limited to preoperative 
variables and does not take into account 
intraoperative or postoperative 
circumstances. It is possible that different 
patient populations, surgical interventions 
and postoperative management may 
affect a predictive ability of a scoring 
system.13 On the other hand, the 
postoperative scores (APACHE II and SOFA 
scores) were predictors of mortality after 
cardiac surgery in our study. So, 
postoperative scores are necessary to 
evaluate the postoperative risk. 
By comparing the postoperative 
scores, we found that both APACHE II and 
SOFA scores have similar predictive values 
(AUC: 0.878, P-value: 0.001) for mortality 
compared to the poor performance of 
CASUS score (AUC: 0.673, P-value: 0.108) 
that failed to predict mortality after cardiac 
surgery.  
Our results regarding the APACHE II 
score are in accordance with Chang et al. 
(2017)16 who studied 483 patients after 
coronary artery bypass grafting (CABG) and 
found that APACHE II score in the first ICU 
day was effective in prediction of mortality 
(AUC: 0.86, P-value <0.001). Other authors 
also demonstrated that APACHEII score at 
ICU admission successfully predicted 30-
day mortality in 150 cardiac surgery 
patients (P-value<0.001).13 This high 
predictive power may be attributed to the 
large number of variables (12 variable) that 
allows more accurate monitoring of organ 
dysfunction. The APACHE II score takes in 
consideration the age, patient co-
morbidities and type of ICU admission 
which are important factors in determining 
prognosis and survival.18 Despite of the 
good performance of the APACHE II score, 
it still cannot guide the clinical decision 
reliably after the first period of ICU 
admission as it is calculated only once in 
the early ICU admission. But, this still can 
be solved if APACHE II score have the 
ability to predict the risk on daily basis.19 
The SOFA score had good ability to 
predict mortality (AUC: 0.878, P-value 
<0.001) in our study. Our results are 
supported by the results of Ceriani et al. 
(2003)20 who calculated SOFA score for the 
first 10 postoperative days in cardiac  
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surgery patients and Patila et al. (2006)21 
who evaluated 857 cardiac surgery 
patients and found that the SOFA score 
predicted mortality accurately in the first 
three days (AUC: 0.76). In a more recent 
study, the SOFA score has the good 
predictive value for 30-day mortality (P-
value <0.001) as reported by 
Exarchopoulos et al. (2015)13. A word of 
caution about SOFA score is that the 
cardiovascular component of the SOFA 
score is based on the administration of 
vasoactive medication using specific 
protocols such as dopamine being 
administered before noradrenaline to 
treat hypotension. In many centers, 
clinicians know that these patterns of drug 
administration are not followed and this 
may lead to diminished confidence in the 
SOFA score despite reports of good 
performance in multiple studies.13,21,22 
Despite the good performance of the SOFA 
score, only the APACHE II score was 
identified as an independent predictor of 
mortality after cardiac surgery by the 
multivariate analysis (P-value= 0.029). This 
disagrees with the results of Chang et al. 
(2017)16 who also highlighted the strong 
power of both SOFA and APACHE II scores 
in predicting mortality but the multivariate 
analysis identified the SOFA score as an 
independent predictor of mortality (P-
value <0.001). 
Table 4: Multivariate logistic regression 
analysis of variables affecting survival 
Variable T P 
Maximum SOFA 1.707 0.103 
APACHE II 2.346 0.029 
Platelets count 2.598 0.017 
PO2 0.108 0.923 
Bilirubin 1.834 0.079 
Ejection fraction 0.098 0.923 
Hosmer-Lemeshow X2 1.49, df 8, p-value 
0.99 
In our study the CASUS score failed to 
predict mortality after cardiac surgery 
(AUC: 0.673, P-value=0.108). On the 
contrary to our results, the CASUS score 
was validated for prediction of 30-day 
mortality by Doerr at al. (2011)22 and 
performed well in the first 6 postoperative 
days after cardiac surgery (AUC: >90) with 
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Table 5: Risk scores and morbidity 
Variable 
ICU stay Hours on ventilation Hospital stay 
r P r P r P 
APACHE II 0.294 0.003 0.478 0.001 -0.054 0.657 
Maximum SOFA 0.499 0.001 0.427 0.001 0.150 0.218 
Maximum CASUS 0.591 0.001 0.522 0.001 0.182 0.135 
the largest AUC on the second ICU day 
(AUC= 0.97). Also, Exarchopoulos et al. 
(2015)13 found that CASUS score showed 
good performance in the first 
postoperative day after cardiac surgery 
(AUC 0.89). The poor results of CASUS 
score in our study in comparison to other 
studies may be attributed to the fact that 
CASUS score takes in consideration the 
lactic acid level and pressure adjusted 
heart rate which are thought to be volatile 
variables and may change continuously.23 
Another reason is the difference in 
populations as it lacks its application in 
different countries and it has not been 
tested in multicenter studies and 
accordingly has not yet gained much 
popularity.7 In fact, these differences in the 
reported results among several studies 
indicate the importance of testing the 
scoring systems in the local environment of 
each surgical center. 
The superiority of APACHE II score in 
our population coincides with an earlier 
study conducted in our center that 
investigated several (trauma-specific and 
general severity of illness) scores for risk 
stratification of mortality in 400 patients 
after thoracic trauma.17 Among the 
investigated scores, APACHE II score 
yielded the highest predictive value of 
mortality in our patient population. 
Another factor that was identified as an 
independent predictor of mortality is the 
preoperative platelet count. In the past 
years the main interest was focused on 
thrombocytopenia and the risk of bleeding 
after cardiac surgery. But recently, The 
platelet count has been proved to play a 
major role in the outcome of 
thromboembolic events such as 
myocardial infarction and stroke.24 During 
cardiopulmonary bypass multiple 
processes occur involving platelets, 
coagulation factors and vascular 
endothelium promoting the shift of risk 
from bleeding to thrombosis that manifest 
as multi-organ complications and worsens 
the outcome.25 In 2000, Vuylsteke and his 
colleagues26 found that the increased 
preoperative platelet count was associated 
with increased heparin resistance due to 
the increased capacity to produce platelet 
factor 4 that neutralizes heparin, the 
platelet count in patients who showed 
heparin resistance was {252 (221 - 270) X 
103/mm3} while normal patients platelet 
count was {194 (165–223) X 103/mm3}. In 
our study we found that the preoperative 
platelet count was higher in non survivors 
{296.87 ± 66.05 X 103/mm3} compared to 
survivors {236.79 ± 66.92 X 103/mm3} and 
this was supported by the results of Unal et 
al. (2013)25 who reported that the 
increased platelet count was correlated 
with adverse events after CABG with The 
reported platelet count in their patients 
with adverse events being 262 ± 66 X 
103/mm3. The increased preoperative 
platelet count is still an area of debate and 
needs more extensive research.  
Regarding other outcome measures, 
our results showed that all the three scores 
are significantly correlated with 
postoperative length of ICU stay and 
duration of mechanical ventilation but 
none of the scores was correlated with the 
postoperative hospital stay. This may be 
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explained by our protocol of patient 
discharge that recommends the discharge 
of patients after valve surgery when INR 
reaches at least 2 to avoid complications 
because of the nature of our patients and 
unavailability of healthcare in many rural 
areas. This will lead eventually to 
prolongation of the hospital stay that is not 
related to morbidity events. 
Limitations of the study: 
The small number of cases as well as single 
center experience might limit the 
generalization of the findings and the 
results to different populations. 
The scoring systems used were 
calculated at different time points in the 
postoperative course of the patient and 
this may affect the results due to the 
possible dynamic changes of the 
postoperative patient status 
Lastly, it is well known that mortality 
in the ICU is multifactorial and is 
dependent on practice. It is possible that 
other several factors that are not included 
in the scoring systems could affect the 
outcome of the patients. 
Conclusion: 
Both APACHE II and SOFA scores showed a 
high power in predicting mortality but 
APACHE II score rises as the best tool for 
risk stratification in our patients. It can be 
used as a guide to develop a local risk 
model but still more extensive studying is 
needed for generalization of the results. 
Results validating the score is a must 
before its use in daily practice and to 
choose a score, patients’ characteristics 
must be considered. Larger studies to 
validate the scores is recommended. 
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